Valneva SE

Valneva SE Declaration of shares and voting rights - Interim status at June 22, 2022

27 июн 2022 02:30:00 Источник Nasdaq GlobeNewswire

Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001

24 июн 2022 12:00:00 Источник Nasdaq GlobeNewswire

Valneva Announces Successful Outcome of its AGM and Appointment of two New Supervisory Board Members

24 июн 2022 01:05:00 Источник Nasdaq GlobeNewswire

Valneva and Pfizer Announce Closing of Equity Investment

23 июн 2022 11:45:00 Источник Nasdaq GlobeNewswire

Valneva announces resumption of trading of its ordinary shares on Euronext Paris

23 июн 2022 10:00:00 Источник Nasdaq GlobeNewswire

Valneva Receives Positive CHMP Opinion for Marketing Authorization of its Inactivated COVID-19 Vaccine Candidate in Europe

23 июн 2022 09:16:12 Источник Nasdaq GlobeNewswire

Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15

20 июн 2022 01:00:00 Источник Nasdaq GlobeNewswire

Valneva Announces Settlement Agreement with the UK Government

15 июн 2022 11:45:00 Источник Nasdaq GlobeNewswire

Valneva Provides Update on European Inactivated, Whole-Virus COVID-19 Vaccine Program VLA2001

10 июн 2022 12:30:00 Источник Nasdaq GlobeNewswire

Valneva Joins Euronext’s Tech Leaders Index

08 июн 2022 02:30:00 Источник Nasdaq GlobeNewswire